Grade I neuroendocrine carcinoma

Clinical trials for Grade I neuroendocrine carcinoma explained in plain language.

Never miss a new study

Get alerted when new Grade I neuroendocrine carcinoma trials appear

Sign up with your email to follow new studies for Grade I neuroendocrine carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New combo attack on stubborn cancers shows promise in early trial

Disease control Completed

This phase II trial tests whether combining the immunotherapy drug nivolumab with the chemotherapy drug temozolomide can shrink tumors in people with small-cell lung cancer that has returned or not responded to treatment, or advanced neuroendocrine tumors. About 55 participants w…

Matched conditions: GRADE I NEUROENDOCRINE CARCINOMA

Phase 2 • Sponsor: Dwight Owen • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Grade I neuroendocrine carcinoma

Get alerted when new Grade I neuroendocrine carcinoma trials appear

New combo attack on stubborn cancers shows promise in early trial